History of Nightscout

The History of Nightscout The story of Nightscout and the #WeAreNotWaiting movement is a compelling example of how the determination of parents and technology enthusiasts forced a real breakthrough in type 1 diabetes care. Below are the key facts worth using in your article. Origins and Early Problems (2013) The project began in February 2013, and its roots were deeply personal. The problem to solve : John Costik, a software engineer from New York, and his wife learned that their 4-year-old son Evan had type 1 diabetes. To keep their child safe, they began using the Dexcom G4 continuous glucose monitoring system (CGM). It soon became clear that there was a serious gap - sensor data was not available remotely. When Evan was at preschool, his parents were completely cut off from information about his blood glucose level, which caused enormous stress and created a real safety risk. The first prototype : Faced with this problem, Costik decided to act. Using his technical knowledge, he wrote a simple application that pulled data from the CGM receiver and sent it to a Google Docs spreadsheet, creating the first basic remote monitoring system. He shared his achievement on Twitter, and that post helped ignite the entire movement. A key person who responded to Costik's call was Lane Desborough , a Canadian chemical engineer whose son also had type 1 diabetes. Desborough, experienced in automating complex industrial systems, was rightly frustrated that he could monitor refineries on the other side of the world but could not check his child's glucose level from the next room. He gave the project the name Nightscoutand significantly expanded its capabilities. Key People in the Project Nightscout was a community effort from the beginning, but several people played especially important roles: John Costik : The initiator and originator of the first solution that made it possible to send CGM data to the cloud. Lane Desborough : A co-creator who developed Costik's concept into a stable, functional system. He is also a co-author of the #WeAreNotWaiting hashtag. Howard Look : Founder of Tidepool, who, together with Desborough, coined the term #WeAreNotWaiting during the "Diabetes Data Exchange" conference in November 2013. Ross Naylor : An engineer who helped turn the early code into a working prototype that became the basis for further development. The "CGM in the Cloud" community : A Facebook group that became the main hub for user support and experience sharing. By 2016, it already had more than 17,000 members. Development and Milestones The path from a makeshift solution to a global open-source project unfolded step by step: 2013 (February) : John Costik creates the first software for remotely reading data from the Dexcom G4 CGM. 2014 : After months of work by a developer community that included Ben West, Jason Calabrese, and Toby Canning, the source code was released publicly as The Nightscout Project. The delay was caused by legal concerns - the creators wanted to make sure that releasing software with potential medical use would be legally safe. 2015 : Dexcom, most likely under pressure from the Nightscout movement, launched its own commercial remote data-sharing system called "Dexcom Share". 2016 : A local Nightscout Poland community was created in Poland. To this day : The project continues to be developed by a global community of volunteers. Nightscout has evolved from simple monitoring into an advanced platform that forms a crucial part of many automated insulin delivery systems, often called a "closed loop". Key Challenges Grassroots innovation did not come without obstacles. The main problems Nightscout faced were described in detail in an article published in 2016 in the respected Journal of the American Medical Association (JAMA): Safety : As an open-source project, Nightscout had no single organization responsible for systematic testing and safety guarantees. Responsibility rested with users. Legal issues : The creators struggled for a long time with whether and how to release software that was, de facto , an unregistered medical device. FDA regulations : The U.S. Food and Drug Administration (FDA) viewed each working Nightscout instance as a potential medical device, raising questions about compliance and liability. Accessibility : At first, the system was difficult to configure and required considerable technical knowledge, limiting its reach to a narrow group of advanced users. Today, Nightscout is a powerful social movement built around a practical technology project. For more than a decade, it has proved that patients and their loved ones, guided by the idea of #WeAreNotWaiting , can create meaningful innovation themselves and push modern medicine in the right direction. Sources: https://en.wikipedia.org/wiki/Nightscout https://nightscout.pl/2017/11/23/1-forum-nowoczesnego-diabetologa-grupa-nightscout-do-tablicy/ https://www.medscape.com/viewarticle/1000380 https://www.shan